Molly V. Wagster - Publications

National Inst. on Aging, Baltimore, MD, United States 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Smith AW, Mitchell SA, K De Aguiar C, Moy C, Riley WT, Wagster MV, M Werner E. News from the NIH: Person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Translational Behavioral Medicine. 6: 470-4. PMID 27528535 DOI: 10.1007/s13142-015-0345-9  0.52
2013 Gershon RC, Wagster MV, Hendrie HC, Fox NA, Cook KF, Nowinski CJ. NIH toolbox for assessment of neurological and behavioral function. Neurology. 80: S2-6. PMID 23479538 DOI: 10.1212/WNL.0b013e3182872e5f  0.52
2012 Wagster MV, King JW, Resnick SM, Rapp PR. The 87%. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 739-40. PMID 22773154 DOI: 10.1093/gerona/gls140  0.52
2012 Berch DB, Wagster MV. Future directions in cognitive aging research: Perspectives from the National Institute on Aging New Frontiers in Cognitive Aging. DOI: 10.1093/acprof:oso/9780198525691.003.0017  0.52
2011 Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, ... ... Wagster MV, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/j.jalz.2011.03.003  0.52
2010 Gershon RC, Cella D, Fox NA, Havlik RJ, Hendrie HC, Wagster MV. Assessment of neurological and behavioural function: the NIH Toolbox. The Lancet. Neurology. 9: 138-9. PMID 20129161 DOI: 10.1016/S1474-4422(09)70335-7  0.52
2009 Wagster MV. Cognitive aging research: an exciting time for a maturing field : a postscript to the special issue of neuropsychology review. Neuropsychology Review. 19: 523-5. PMID 19943133 DOI: 10.1007/s11065-009-9121-2  0.52
2007 Morrison-Bogorad M, Cahan V, Wagster MV. Brain health interventions: the need for further research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: S80-5. PMID 19595981 DOI: 10.1016/j.jalz.2007.01.015  0.52
2007 Albert MS, Brown DR, Buchner D, Laditka J, Launer LJ, Scherr P, Thies W, Wagster MV. The healthy brain and our aging population: translating science to public health practice. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: S3-5. PMID 19595971 DOI: 10.1016/j.jalz.2007.01.016  0.52
2007 Elias JW, Wagster MV. Developing context and background underlying cognitive intervention/training studies in older populations. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 62: 5-10. PMID 17565160 DOI: 10.1093/geronb/62.special_issue_1.5  0.52
2006 Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, Yaffe K, Cuthbert BN, Edwards E, Wagster MV. The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 12-32. PMID 19595852 DOI: 10.1016/j.jalz.2005.11.004  0.52
2002 Edwards E, Kitt C, Oliver E, Finkelstein J, Wagster M, McDonald WM. Depression and Parkinson's disease: A new look at an old problem Depression and Anxiety. 16: 39-48. PMID 12203670 DOI: 10.1002/da.10057  0.52
1998 Rosenblatt A, Ranen NG, Rubinsztein DC, Stine OC, Margolis RL, Wagster MV, Becher MW, Rosser AE, Leggo J, Hodges JR, ffrench-Constant CK, Sherr M, Franz ML, Abbott MH, Ross CA. Patients with features similar to Huntington's disease, without CAG expansion in huntingtin. Neurology. 51: 215-20. PMID 9674805  0.52
1998 Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA. Frontal lobe volume in patients with Huntington's disease. Neurology. 50: 252-8. PMID 9443488  0.52
1997 Becher MW, Rubinsztein DC, Leggo J, Wagster MV, Stine OC, Ranen NG, Franz ML, Abbott MH, Sherr M, MacMillan JC, Barron L, Porteous M, Harper PS, Ross CA. Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 519-30. PMID 9251070 DOI: 10.1002/mds.870120408  0.52
1996 Margolis RL, Li SH, Young WS, Wagster MV, Stine OC, Kidwai AS, Ashworth RG, Ross CA. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. Brain Research. Molecular Brain Research. 36: 219-26. PMID 8965642 DOI: 10.1016/0169-328X(95)00241-J  0.52
1996 Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proceedings of the National Academy of Sciences of the United States of America. 93: 5037-42. PMID 8643525 DOI: 10.1073/pnas.93.10.5037  0.52
1995 Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron. 14: 1065-74. PMID 7748554 DOI: 10.1016/0896-6273(95)90345-3  0.52
1995 Stine OC, Li SH, Pleasant N, Wagster MV, Hedreen JC, Ross CA. Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients. Human Molecular Genetics. 4: 15-8. PMID 7711729 DOI: 10.1093/hmg/4.1.15  0.52
1995 Schilling G, Sharp AH, Loev SJ, Wagster MV, Li SH, Stine OC, Ross CA. Expression of the Huntington's disease (IT15) protein product in HD patients. Human Molecular Genetics. 4: 1365-71. PMID 7581375 DOI: 10.1093/hmg/4.8.1365  0.52
1994 Wagster MV, Hedreen JC, Peyser CE, Folstein SE, Ross CA. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease. Experimental Neurology. 127: 70-5. PMID 7515353 DOI: 10.1006/exnr.1994.1081  0.52
1993 Wagster MV. Changes in cholinergic receptor subtypes in behaviorally-tested, aged monkeys. Neurobiology of Aging. 14: 693-4. PMID 8295691 DOI: 10.1016/0197-4580(93)90075-M  0.52
1993 Li SH, Schilling G, Young WS, Li XJ, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 11: 985-93. PMID 8240819 DOI: 10.1016/0896-6273(93)90127-D  0.52
1991 Price DL, Martin LJ, Sisodia SS, Wagster MV, Koo EH, Walker LC, Koliatsos VE, Cork LC. Aged non-human primates: an animal model of age-associated neurodegenerative disease. Brain Pathology (Zurich, Switzerland). 1: 287-96. PMID 1688300  0.52
1990 Price DL, Koo EH, Wagster MV, Walker LC, Wenk GL, Applegate MD, Kitt CA, Cork LC. Behavioral, cellular, and molecular biological studies of aged nonhuman primates. Advances in Neurology. 51: 83-9. PMID 2403719  0.52
1990 Wagster MV, Whitehouse PJ, Walker LC, Kellar KJ, Price DL. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2879-85. PMID 2398366  0.52
1990 Filloux F, Wagster MV, Folstein S, Price DL, Hedreen JC, Dawson TM, Wamsley JK. Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin binding. Experimental Neurology. 110: 219-27. PMID 2146140 DOI: 10.1016/0014-4886(90)90033-O  0.52
1989 Atack JR, Wenk GL, Wagster MV, Kellar KJ, Whitehouse PJ, Rapoport SI. Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Research. 483: 367-72. PMID 2706526 DOI: 10.1016/0006-8993(89)90182-0  0.52
1988 Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38: 720-3. PMID 3362368  0.52
1988 Walker LC, Kitt CA, Struble RG, Wagster MV, Price DL, Cork LC. The neural basis of memory decline in aged monkeys. Neurobiology of Aging. 9: 657-66. PMID 3145465 DOI: 10.1016/S0197-4580(88)80130-1  0.52
Show low-probability matches.